DNA Methylation Biomarkers-Based Human Age Prediction Using Machine Learning

Abstract

Purpose. Age can be an important clue in uncovering the identity of persons that left biological evidence at crime scenes. With the availability of DNA methylation data, several age prediction models are developed by using statistical and machine learning methods. From epigenetic studies, it has been demonstrated that there is a close association between aging and DNA methylation. Most of the existing studies focused on healthy samples, whereas diseases may have a significant impact on human age. Therefore, in this article, an age prediction model is proposed using DNA methylation biomarkers for healthy and diseased samples. Methods. The dataset contains 454 healthy samples and 400 diseased samples from publicly available sources with age (1–89 years old). Six CpG sites are identified from this data having a high correlation with age using Pearson’s correlation coefficient. In this work, the age prediction model is developed using four different machine learning techniques, namely, Multiple Linear Regression, Support Vector Regression, Gradient Boosting Regression, and Random Forest Regression. Separate models are designed for healthy and diseased data. The data are split randomly into 80 : 20 ratios for training and testing, respectively. Results. Among all the techniques, the model designed using Random Forest Regression shows the best performance, and Gradient Boosting Regression is the second best model. In the case of healthy samples, the model achieved a MAD of 2.51 years for training data and 4.85 for testing data. Also, for diseased samples, a MAD of 3.83 years is obtained for training and 9.53 years for testing. Conclusion. These results showed that the proposed model can predict age for healthy and diseased samples.

Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures

“…Artificial intelligence (AL) is an emerging area which aims at designing computer structures that simulate human intelligence. Machine learning (ML) comes under AI that design advance algorithms in helping to understand the disease behavior [ 172 ]. Accumulated data evidenced that ML can improve the breast cancer diagnosis and help predict the prognosis.…”

An ELOVL2-Based Epigenetic Clock for Forensic Age Prediction: A Systematic Review

“…More recently, forensic DNA technology has triggered efforts toward simplification of the array-based epigenetic clocks, and several models have been developed to date. Due to the existence of complex nonlinear relationships between the methylation levels of the assessed CpG markers and chronological age, several authors have also taken advantage of machine learning approaches to obtain more accurate age predictions [7,8]. These algorithms include support vector machine (SVM) [9], artificial neural networks [10], gradient boosting regressor [11], and missMDA [8].…”

Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance

“…Till now, several modes of epigenetic regulation such as DNA methylation (hypomethylation and hypermethylation of gene promotor), histone modifications (methylation or acetylation etc.) (Zaguia et al, 2022), abnormal expression of microRNAs (miRNAs), long non-coding RNAs, and small nucleolar RNAs, have been discovered and documented (Ilm et al, 2016;Shanmugam et al, 2018). Moreover, important roles of each mode have been assessed in diverse pathological conditions (Jaenisch and Bird, 2003;Das and Singal, 2004;Kurdistani, 2007;Goel et al, 2017;Kashyap et al, 2018;Karir et al, 2020;Kashyap and Kaur, 2020).…”